Granahan Investment Management, LLC Intellia Therapeutics, Inc. Transaction History
Granahan Investment Management, LLC
- $2.12 Billion
- Q4 2024
A detailed history of Granahan Investment Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 306,510 shares of NTLA stock, worth $3.75 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
306,510
Previous 283,534
8.1%
Holding current value
$3.75 Million
Previous $5.83 Million
38.67%
% of portfolio
0.17%
Previous 0.25%
Shares
30 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$154 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$125 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$63.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$46.7 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $931M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...